Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010505

CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 3,932 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-08 Option exercise +3,932 22,994 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-08 Shares withheld for taxes −1,666 $17.90 $29,821 21,328 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-04 Grant or award · Share Option +18,900 18,900 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-04 Grant or award · Restricted Share Unit +9,450 17,122 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-04-08 Option exercise · Restricted Share Unit −3,932 13,190 D
Loading xslF345X05/form4-04082024_090419.xml…